Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy
血浆 miR-142 作为双重抗血小板治疗的中间生物标志物可预测重大不良心血管事件
期刊:Acta Pharmacologica Sinica
影响因子:6.9
doi:10.1038/s41401-018-0041-7
Qian-Jie Tang, He-Ping Lei, Hong Wu, Ji-Yan Chen, Chun-Yu Deng, Wang-Sheng Sheng, Yong-Heng Fu, Xiao-Hong Li, Yu-Bi Lin, Ya-Ling Han, Shi-Long Zhong
